Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects
NCT06308393 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 98
Last updated 2025-05-02
Summary
Randomized, double-blind, placebo-controlled study of RSS0393 ointment in healthy and psoriatic subjects
Conditions
- Healthy
- Psoriatic Subjects
Interventions
- DRUG
-
RSS0393 ointment;Placebo
RSS0393 ointment;RSS0393 ointment placebo
Sponsors & Collaborators
-
Jiangsu HengRui Medicine Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-03-01
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- China
Study Locations
More Related Trials
-
Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients
NCT02908347 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.
NCT06396013 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis
NCT02932462 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
NCT01938599 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
NCT01194219 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
NCT03895372 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy
NCT03930186 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Treatment Patterns and Clinical Outcomes of Psoriasis in Japan
NCT04826536 ·Status: COMPLETED
-
The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis
NCT06833307 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Topical Aprepitant in Prurigo Patients
NCT01963793 ·Status: COMPLETED ·Phase: PHASE2
-
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
NCT03210961 ·Status: COMPLETED ·Phase: PHASE1
-
Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis
NCT00617994 ·Status: COMPLETED ·Phase: PHASE2
-
Sequential Treatment of Psoriasis With Integrated Traditional Chinese and Western Medicine
NCT03941431 ·Status: UNKNOWN ·Phase: PHASE2
-
Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test
NCT03004339 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis
NCT03850483 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
NCT01871402 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis
NCT05896527 ·Status: COMPLETED ·Phase: PHASE2
-
STA-21 Topical Efficacy on Psoriasis
NCT01047943 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.
NCT00417820 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis
NCT04971239 ·Status: UNKNOWN ·Phase: PHASE4
-
1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat
NCT03399526 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)
NCT01882647 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis
NCT03832738 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis
NCT05268016 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis
NCT01206387 ·Status: COMPLETED ·Phase: PHASE3